Cargando…
Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor, and surgical resection is the first choice for the treatment of the disease, but since the advent of tyrosine kinase inhibitors (TKIs) such as imatinib (IM), the prognosis of the disease has undergone revolutionary changes....
Autores principales: | Xu, Hao, Liu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804055/ https://www.ncbi.nlm.nih.gov/pubmed/33456310 http://dx.doi.org/10.2147/OTT.S279998 |
Ejemplares similares
-
Management of hemorrhage in gastrointestinal stromal tumors: a review
por: Liu, Qi, et al.
Publicado: (2018) -
Current clinical management of gastrointestinal stromal tumor
por: Akahoshi, Kazuya, et al.
Publicado: (2018) -
Recent advances in managing gastrointestinal stromal tumor
por: Duffaud, Florence, et al.
Publicado: (2017) -
Recent advances in the management of gastrointestinal stromal tumors
por: Duffaud, Florence, et al.
Publicado: (2010) -
Recent advances in the management of gastrointestinal stromal tumor
por: Ahmed, Monjur
Publicado: (2020)